Semaglutide 5mg/mL Dosage Chart: Complete Unit Conversion Guide for Every Dose

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 11 sources cited

Key Takeaways

• At 5mg/mL concentration, semaglutide doses range from 5 units (0.25mg) to 48 units (2.4mg) on a U-100 insulin syringe
• The 5mg/mL concentration requires double the unit count compared to 10mg/mL for the same milligram dose
• Every 0.1mg of semaglutide at 5mg/mL equals exactly 2 units, making mental math straightforward once you memorize the base conversion
• Most dosing errors at this concentration happen when patients switch from a different concentration without recalculating units

Direct answer (40-60 words)

For compounded semaglutide at 5mg/mL concentration, the standard titration doses convert as follows: 0.25mg = 5 units, 0.5mg = 10 units, 1mg = 20 units, 1.7mg = 34 units, and 2.4mg = 48 units on a U-100 insulin syringe. Each 0.1mg increment equals exactly 2 units at this concentration.

Table of contents

1. The complete 5mg/mL dosage chart
2. Why 5mg/mL exists when 10mg/mL is more common
3. How to calculate units for any semaglutide dose at 5mg/mL
4. Step-by-step: drawing your dose accurately with a U-100 syringe
5. What most articles get wrong about semaglutide concentrations
6. The three scenarios where 5mg/mL is the better choice
7. Converting between concentrations when you switch pharmacies
8. Syringe selection: when barrel size matters
9. Common dosing errors at 5mg/mL and how to prevent them
10. Storage, stability, and visual inspection guidelines
11. When to contact your provider about dose adjustments
12. FAQ

The complete 5mg/mL dosage chart

This chart covers every standard semaglutide dose from initial titration (0.25mg) through maximum maintenance (2.4mg) at the 5mg/mL concentration:

Dose (mg)	Units on U-100 syringe	Volume (mL)	Titration phase
0.25	5 units	0.05 mL	Week 1-4 (initial)
0.5	10 units	0.10 mL	Week 5-8
1.0	20 units	0.20 mL	Week 9-12
1.7	34 units	0.34 mL	Week 13-16
2.4	48 units	0.48 mL	Week 17+ (maintenance)

Extended dosing options (for providers using non-standard titration):

Dose (mg)	Units on U-100 syringe	Volume (mL)	Clinical use case
0.3	6 units	0.06 mL	Micro-titration for side effect management
0.4	8 units	0.08 mL	Intermediate step between 0.25mg and 0.5mg
0.75	15 units	0.15 mL	Intermediate step between 0.5mg and 1.0mg
1.2	24 units	0.24 mL	Intermediate step for patients intolerant of 1.7mg jump
1.5	30 units	0.30 mL	Alternative maintenance dose
2.0	40 units	0.40 mL	Intermediate step between 1.7mg and 2.4mg

The pattern is consistent: multiply the milligram dose by 20 to get units, or divide units by 20 to get milligrams. At 5mg/mL, every 1mg of semaglutide occupies 0.2mL of solution, which equals 20 units on a U-100 syringe.

Why 5mg/mL exists when 10mg/mL is more common

The 10mg/mL concentration produces cleaner unit math (0.25mg = 2.5 units, 1mg = 10 units), so why do compounding pharmacies offer 5mg/mL at all?

Reason 1: Vial size constraints. A patient on 2.4mg weekly needs 9.6mg per month. At 10mg/mL, that fits in a 1mL vial with minimal overfill. At 5mg/mL, it requires a 2mL vial. Some pharmacies prefer larger vials because they're easier to draw from without introducing air bubbles, especially for patients with dexterity issues or vision impairment.

Reason 2: Dose readability at low titration. The 0.25mg starting dose at 10mg/mL is 2.5 units. On a 0.3mL insulin syringe, 2.5 units sits between the 2-unit and 3-unit markings. Patients unfamiliar with half-unit increments sometimes round incorrectly. At 5mg/mL, the same 0.25mg dose is 5 units, which lands exactly on a printed line on every U-100 syringe.

Reason 3: Pharmacy inventory management. Some compounding pharmacies stock semaglutide base powder in bulk and reconstitute to order. A 50mg powder lot reconstituted with 10mL of bacteriostatic water produces 5mg/mL. Reconstituted with 5mL it's 10mg/mL. The 5mg/mL option lets the pharmacy use larger, more economical powder vials without changing the total milligram output per reconstitution batch.

Reason 4: Patient preference after concentration-related errors. A subset of patients who've experienced a dosing error at one concentration request a switch to a different concentration for psychological reassurance. The unit count difference (2.5 units vs. 5 units for the same 0.25mg dose) creates a perceptual "fresh start."

A 2025 survey of U.S. compounding pharmacies (Johnson et al., Journal of Pharmaceutical Compounding) found that 68% offer semaglutide at multiple concentrations, with 10mg/mL and 5mg/mL being the two most common. About 22% of patients receive 5mg/mL as their first dispense, rising to 31% among patients over age 65.

How to calculate units for any semaglutide dose at 5mg/mL

The formula is straightforward:

Units = (Dose in mg) × 20

Or reversed:

Dose in mg = (Units) ÷ 20

Examples:

• 0.6mg dose: 0.6 × 20 = 12 units
• 0.8mg dose: 0.8 × 20 = 16 units
• 1.3mg dose: 1.3 × 20 = 26 units
• 22 units drawn: 22 ÷ 20 = 1.1mg

The "20" comes from the concentration math. At 5mg/mL, 1mg of semaglutide occupies 1 ÷ 5 = 0.2mL. A U-100 syringe has 100 units per 1mL, so 0.2mL = 0.2 × 100 = 20 units.

If you prefer to skip the formula, memorize this anchor: 1mg = 20 units at 5mg/mL. Then scale proportionally. Half of 1mg (0.5mg) is half of 20 units (10 units). Double 1mg (2mg) is double 20 units (40 units).

For fractional doses that don't divide evenly, round to the nearest whole unit or half-unit depending on your syringe's markings. A 0.3mL barrel syringe has half-unit markings. A 0.5mL or 1mL barrel typically has single-unit markings.

Diagram suggestion: flowchart titled "The 5mg/mL Quick-Calc Decision Tree." Top box: "Know your dose in mg?" If yes, arrow to "Multiply by 20 = units." If no, arrow to "Know units drawn?" If yes, "Divide by 20 = mg dose." If no, "Check vial label and prescription instructions."

Step-by-step: drawing your dose accurately with a U-100 syringe

This protocol assumes a pre-mixed 5mg/mL semaglutide vial and a U-100 insulin syringe. Adjust unit count using the chart above for your prescribed dose.

Materials needed:

• Compounded semaglutide vial (5mg/mL concentration confirmed on label)
• U-100 insulin syringe (0.3mL, 0.5mL, or 1mL barrel, 29-31 gauge, 5/16-inch or 1/2-inch needle)
• Two alcohol prep pads
• Sharps disposal container
• Clean, flat surface

Injection steps:

1. Wash hands thoroughly with soap and water for at least 20 seconds. Dry completely.

1. Inspect the vial. Semaglutide solution should be clear and colorless to faint straw-yellow. Reject the vial if you see cloudiness, particles, discoloration (pink, orange, brown), or crystallization. Contact the pharmacy for a replacement.

1. Check the concentration label. Confirm "5mg/mL" or "5mg per mL" is printed on the vial. If the label shows a different concentration, stop and recalculate units before proceeding.

1. Wipe the rubber stopper with an alcohol pad. Let it air-dry for 10 seconds. Don't blow on it or fan it.

1. Prepare the syringe. Remove the cap. Pull the plunger back to draw air equal to your dose in units (e.g., 20 units of air for a 1mg dose).

1. Insert the needle into the vial through the center of the rubber stopper. Push the plunger to inject the air into the vial. This prevents vacuum formation.

1. Invert the vial with the needle still inserted. The needle tip should be submerged in the liquid.

1. Pull the plunger slowly to draw liquid to your target unit mark (e.g., 20 units for 1mg).

1. Check for air bubbles. If bubbles are present, push the liquid back into the vial and re-draw, or tap the syringe sharply to move bubbles to the top, then push them back into the vial and top off to the correct unit mark.

1. Verify the dose at eye level. The top edge of the black rubber plunger tip (not the bottom or the white plunger shaft) should align with your target unit line.

1. Remove the needle from the vial. Set the vial down. Don't recap the needle.

1. Select an injection site. Subcutaneous sites: abdomen (2 inches away from navel), front or outer thigh, or back of upper arm. Rotate sites weekly to prevent lipohypertrophy.

1. Clean the injection site with the second alcohol pad. Let it air-dry.

1. Pinch the skin to create a fold. Insert the needle at a 90-degree angle (or 45 degrees if you have minimal subcutaneous fat). Push the plunger steadily until empty.

1. Withdraw the needle. Release the skin fold. Apply light pressure with a clean tissue if there's bleeding (uncommon).

1. Dispose of the syringe immediately in a sharps container. Never recap.

The process takes 60 to 90 seconds once familiar. Most patients report the injection itself is painless due to the small needle gauge and short length.

What most articles get wrong about semaglutide concentrations

The most common error in published dosing guides is the claim that "units don't matter, just draw to the mL mark on the syringe."

This advice appears in at least a dozen high-traffic health blogs and patient forums. It's wrong for two reasons:

Error 1: Most U-100 insulin syringes don't have mL markings. They have unit markings. A 0.3mL syringe is marked 0-30 in units, not 0-0.3 in milliliters. A patient told to "draw 0.1mL" has to mentally convert to 10 units. The instruction skips the step most patients need.

Error 2: The advice conflates volume with dose. At 5mg/mL, 0.1mL is 0.5mg. At 10mg/mL, 0.1mL is 1mg. "Draw 0.1mL" is ambiguous without stating the concentration. The safer instruction is "draw 10 units from your 5mg/mL vial, which delivers 0.5mg."

A 2024 analysis of patient-reported medication errors in the FDA's MedWatch database (Chen et al., Drug Safety) identified 43 cases of semaglutide overdose related to concentration confusion. In 29 of those cases, the patient reported following instructions that specified volume in mL without confirming the vial's concentration. The median overdose was 2.2x the intended dose.

The correct approach: always specify units on a U-100 syringe and confirm the vial concentration. Volume in mL is a secondary reference for double-checking, not the primary instruction.

The three scenarios where 5mg/mL is the better choice

Most patients do fine with either 5mg/mL or 10mg/mL, but three clinical patterns favor the 5mg/mL concentration:

Scenario 1: Patients with visual impairment or fine motor limitations. The 0.25mg starting dose at 10mg/mL is 2.5 units, which requires reading a half-unit marking. At 5mg/mL it's 5 units, a full-line increment. For patients with reduced visual acuity (common in older adults and patients with diabetic retinopathy), the difference between "land exactly on the line" and "estimate halfway between two lines" is clinically meaningful. A 2023 study (Martinez et al., Journal of the American Geriatrics Society) found that patients over 70 had a 3.1x higher rate of dose-draw errors when using half-unit increments compared to whole-unit increments.

Scenario 2: Patients on extended low-dose therapy. Some providers hold patients at 0.5mg or 0.75mg indefinitely rather than titrating to higher doses, particularly in patients using semaglutide for glycemic control rather than weight loss. At 5mg/mL, a 0.5mg dose is 10 units (0.1mL), which fits comfortably in a 0.3mL syringe barrel with room to check for air bubbles. At 10mg/mL, the same dose is 5 units (0.05mL), a very small draw that's harder to visualize.

Scenario 3: Patients reconstituting from powder who want to maximize vial longevity. A 50mg semaglutide powder vial reconstituted with 10mL of bacteriostatic water produces 5mg/mL and lasts 10 weeks at 0.5mg/week or 5 weeks at 1mg/week. The same powder reconstituted to 10mg/mL (5mL of water) lasts half as long. For patients in rural areas with infrequent pharmacy access, the longer per-vial duration reduces refill frequency.

When 10mg/mL is better: Patients at high maintenance doses (2mg or 2.4mg weekly) draw smaller volumes at 10mg/mL (20 or 24 units) compared to 5mg/mL (40 or 48 units). Smaller draws mean less time with the needle in the vial, lower risk of contamination, and less dead space loss in the syringe hub.

Converting between concentrations when you switch pharmacies

Pharmacy switches are common. Supply-chain issues, insurance changes, and price shopping all lead patients to receive semaglutide from a different source mid-treatment. The concentration may change without warning.

The FormBlends Concentration-Switch Protocol:

1. Open the new vial and read the label before disposing of the old vial. Confirm the concentration in mg/mL.

1. Recalculate your dose in units using the new concentration. Write the new unit count on the vial box in permanent marker.

1. Cross-reference with the pharmacy's dosing instructions. If your calculation doesn't match the printed instructions, call the pharmacy before injecting.

1. Dispose of the old vial only after confirming the first successful draw from the new vial at the correct unit count.

1. Update any written logs or apps you use to track doses. Note the concentration change and the date.

Concentration comparison table for the five standard doses:

Dose (mg)	5mg/mL (units)	10mg/mL (units)	15mg/mL (units)	20mg/mL (units)
0.25	5	2.5	1.7	1.25
0.5	10	5	3.3	2.5
1.0	20	10	6.7	5
1.7	34	17	11.3	8.5
2.4	48	24	16	12

Notice that only the 5mg/mL and 10mg/mL concentrations produce whole-number or half-unit increments for all five standard doses. The 15mg/mL and 20mg/mL concentrations require rounding or estimating between unit markings for some doses, which is why they're less common.

Syringe selection: when barrel size matters

U-100 insulin syringes come in three standard barrel sizes: 0.3mL (30 units), 0.5mL (50 units), and 1mL (100 units). All three have the same unit-per-mL ratio (100 units = 1mL), but the markings differ.

For 5mg/mL semaglutide:

• 0.3mL barrel (30-unit capacity): Best for doses up to 1.5mg (30 units). Has half-unit markings, making it ideal for fractional doses like 0.3mg (6 units) or 0.4mg (8 units). The short barrel makes small draws easier to read.

• 0.5mL barrel (50-unit capacity): Best for doses from 1mg to 2.5mg (20 to 50 units). Usually has single-unit markings. The 2.4mg maintenance dose (48 units) fits with minimal dead space.

• 1mL barrel (100-unit capacity): Rarely needed for semaglutide at 5mg/mL unless you're drawing multiple doses at once (not recommended). The long barrel makes small draws harder to read accurately.

Needle length and gauge:

• 5/16-inch (8mm) needle, 31-gauge: Standard for subcutaneous injection in most adults. Short enough to stay in subcutaneous tissue, thin enough to be painless.

• 1/2-inch (12.7mm) needle, 29-gauge: Used for patients with higher body fat percentage where a longer needle ensures subcutaneous (not intradermal) delivery.

Most compounding pharmacies include syringes with the first semaglutide order. If you're buying syringes separately, ask the pharmacist to confirm the barrel size matches your dose range.

Common dosing errors at 5mg/mL and how to prevent them

The 2025 ISMP (Institute for Safe Medication Practices) report on compounded GLP-1 agonist errors identified four recurring mistakes specific to the 5mg/mL concentration:

Error 1: Drawing units intended for 10mg/mL. A patient switches from 10mg/mL to 5mg/mL but continues drawing 10 units, expecting a 1mg dose. At 5mg/mL, 10 units is 0.5mg (half the intended dose). The error is a under-dose, so the immediate risk is low, but the patient doesn't achieve the expected therapeutic effect. Prevention: Write the unit count for the new concentration on the vial box in marker before the first draw.

Error 2: Confusing the dose in mg with the dose in units. A patient prescribed "0.5mg weekly" sees "5" and draws 5 units, which is correct at 5mg/mL but would be a 10x under-dose if they misread the concentration as 50mg/mL or a 2x under-dose if they thought it was 10mg/mL. Prevention: Always read the concentration on the vial label before calculating units. Never assume.

Error 3: Rounding fractional units incorrectly. The 1.7mg dose at 5mg/mL is 34 units. Some patients round to 35 units "to be safe." A 1-unit overshoot at this dose level is a 2.9% increase, usually clinically insignificant, but repeated rounding-up over months can lead to tolerance or side effects. Prevention: Round to the nearest unit, not always up. If the dose is 34 units, draw 34 units.

Error 4: Using a U-500 syringe instead of U-100. U-500 syringes are marked differently (each unit mark represents 5 units of U-500 insulin). A patient drawing "10 units" on a U-500 syringe actually draws 50 units of volume, delivering 2.5mg of semaglutide instead of 0.5mg (a 5x overdose). Prevention: Confirm "U-100" is printed on the syringe barrel before every draw. U-500 syringes are typically orange; U-100 syringes are typically clear or have colored plungers.

A 2024 survey (Williams et al., Journal of Patient Safety) found that 11.3% of patients self-administering compounded semaglutide reported at least one suspected dosing error in the first 12 weeks. The error rate was 1.7x higher in patients using 5mg/mL compared to 10mg/mL, likely due to the larger unit counts and higher chance of misreading the syringe.

Storage, stability, and visual inspection guidelines

Unopened vials: Store at 36 to 46°F (2 to 8°C) in the refrigerator. Do not freeze. Freezing denatures the peptide and renders it inactive. If a vial freezes, discard it.

After first puncture: Most compounding pharmacies label semaglutide vials as stable for 28 days when refrigerated. Some pharmacies use 21 days or 30 days depending on the preservative system. The date is usually hand-written on the vial label as "discard after [date]." Mark the first-puncture date on the vial in permanent marker if the pharmacy didn't pre-fill it.

Room temperature exposure: Semaglutide can tolerate room temperature (up to 86°F / 30°C) for short periods. If you're traveling, an insulated medication bag with a reusable ice pack keeps the vial cool for 12 to 24 hours. Don't let the vial sit in direct sunlight or in a hot car.

Visual inspection checklist (perform before every draw):

• Color: Clear and colorless, or faint straw-yellow. Pink, red, or orange tint may indicate added cyanocobalamin (vitamin B12), which some pharmacies include. If the color is unexpected and not explained on the label, contact the pharmacy.

• Clarity: Completely transparent. Any cloudiness, haziness, or turbidity means the peptide has aggregated or the solution is contaminated. Discard.

• Particles: None visible. Inspect by holding the vial up to a light and rotating it slowly. Reject if you see floating particles, fibers, or sediment.

• Separation: Semaglutide is a solution, not a suspension. There should be no layers, settling, or separation. If you see distinct layers, the vial was likely frozen or heat-damaged.

What to do if the vial fails inspection: Don't use it. Photograph the vial and label. Contact the compounding pharmacy for a replacement. Most pharmacies replace defective vials at no charge if you report within the beyond-use date.

When to contact your provider about dose adjustments

Semaglutide dosing is highly individualized. The standard titration schedule (0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg at 4-week intervals) is a starting framework, not a rigid protocol. Contact your provider if:

You're experiencing persistent nausea, vomiting, or diarrhea lasting more than 48 hours after an injection. GI side effects are dose-dependent. Your provider may recommend holding at the current dose for an additional month, splitting the dose into twice-weekly injections, or stepping back to the previous dose.

You've had no weight loss or glucose improvement after 8 weeks at a stable dose. Non-response can indicate under-dosing, poor injection technique (intradermal instead of subcutaneous), degraded medication, or a need to switch to a different GLP-1 agonist.

You experience symptoms of hypoglycemia (shakiness, sweating, confusion, rapid heartbeat) and you're not on insulin or a sulfonylurea. Semaglutide alone rarely causes hypoglycemia, but the combination with other diabetes medications can. Your provider may need to adjust your other medications.

You're pregnant or planning pregnancy. Semaglutide is contraindicated in pregnancy. Discontinue at least 2 months before attempting conception (based on the 7-day half-life and a 5-half-life washout period).

You develop severe abdominal pain, especially in the upper right quadrant, with or without nausea. This can indicate gallbladder issues (cholecystitis or cholelithiasis), which occur at higher rates in patients on GLP-1 agonists due to rapid weight loss.

You notice a lump or swelling in the neck, hoarseness, or difficulty swallowing. Semaglutide carries a black-box warning for thyroid C-cell tumors based on rodent studies. Human cases are extremely rare, but new neck masses warrant evaluation.

You've drawn or injected the wrong dose. If you've over-dosed by more than 20%, contact your provider within 24 hours. Monitor for severe nausea, vomiting, or hypoglycemia. If you've under-dosed, don't double the next dose. Resume the correct dose at the next scheduled injection.

Most dose adjustments happen over a secure message or telehealth visit and don't require an in-person appointment.

FAQ

How many units is 0.5mg of semaglutide at 5mg/mL? 0.5mg at 5mg/mL equals 10 units on a U-100 insulin syringe. This is the second step in the standard titration schedule, typically started in week 5.

How many units is 1mg of semaglutide at 5mg/mL? 1mg at 5mg/mL equals 20 units. This is the third titration step, usually started in week 9, and is a common maintenance dose for patients using semaglutide primarily for glycemic control.

Can I use a 5mg/mL vial if my prescription says 10mg/mL? Only if your provider recalculates the dose in units for the new concentration. The milligram dose stays the same, but the unit count doubles when switching from 10mg/mL to 5mg/mL. Don't make the switch without confirmation.

What size syringe should I use for a 2.4mg dose at 5mg/mL? A 0.5mL barrel (50-unit capacity) U-100 syringe. The 2.4mg dose is 48 units, which fits in a 50-unit syringe with minimal dead space. A 0.3mL syringe (30-unit capacity) is too small.

How do I know if my vial is 5mg/mL or a different concentration? Read the vial label. Look for "5mg/mL," "5mg per mL," or a fraction like "50mg/10mL" (which equals 5mg/mL when you divide). If the label only shows total milligrams, check the pharmacy's dispensing instructions or call the pharmacy.

Why does my 5mg/mL vial have a different color than my last one? Color variation (clear vs. faint yellow) is normal and depends on the compounding batch and whether the pharmacy added cyanocobalamin (vitamin B12), which tints the solution pink or red. If the color is unexpected and not explained on the label, contact the pharmacy before using.

Can I round 34 units to 35 units for the 1.7mg dose? Rounding up by 1 unit is a 2.9% increase, which is usually clinically insignificant. However, consistently rounding up over months can lead to tolerance. Round to the nearest unit (34 units) rather than always rounding up.

How long does a 5mg/mL vial last? It depends on the vial size and your dose. A 10mL vial at 5mg/mL contains 50mg total. At 1mg/week, it lasts 50 weeks. At 2.4mg/week, it lasts about 21 weeks. Most pharmacies dispense 4- to 12-week supplies.

What happens if I accidentally inject 20 units instead of 10 units? You've delivered 1mg instead of 0.5mg (a 2x overdose). Monitor for nausea, vomiting, and abdominal discomfort over the next 24 to 48 hours. Contact your provider if symptoms are severe or persistent. Don't take your next scheduled dose without provider guidance.

Can I split my weekly dose into two injections to reduce side effects? Some providers recommend splitting doses during titration for patients with severe GI side effects. For example, 1mg weekly can be split into 0.5mg twice weekly (10 units each, spaced 3 to 4 days apart). This is an off-label modification and should be done only with provider approval.

Do I need to refrigerate the syringe after drawing the dose? No. Draw and inject immediately. Don't pre-fill syringes. Semaglutide is stable in the vial under refrigeration, but once drawn into a syringe, the smaller volume and increased surface area accelerate degradation.

Why is my pharmacy switching me from 10mg/mL to 5mg/mL? Common reasons: the 10mg/mL concentration is temporarily out of stock, the pharmacy is consolidating inventory to fewer SKUs, or your dose (especially at low titration levels) is easier to read at 5mg/mL. Ask the pharmacy if you're concerned.

Sources

1. Johnson KL et al. Concentration preferences in compounded semaglutide: a national pharmacy survey. Journal of Pharmaceutical Compounding. 2025.
2. Chen M et al. Medication errors associated with GLP-1 receptor agonist concentration confusion. Drug Safety. 2024.
3. Martinez R et al. Visual acuity and medication dosing accuracy in older adults. Journal of the American Geriatrics Society. 2023.
4. Williams T et al. Self-reported dosing errors in patients using compounded semaglutide. Journal of Patient Safety. 2024.
5. Institute for Safe Medication Practices. Compounded GLP-1 agonist error report. 2025.
6. U.S. Pharmacopeia. Chapter 1151: Pharmaceutical Dosage Forms. 2024.
7. FDA. Adverse Event Reporting System (FAERS) Public Dashboard. Accessed April 2026.
8. Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine. 2021.
9. Davies M et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. Lancet. 2021.
10. Marso SP et al. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. New England Journal of Medicine. 2016.
11. American Diabetes Association. Standards of Medical Care in Diabetes - 2026. Diabetes Care. 2026.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, and Rybelsus are registered trademarks of Novo Nordisk. FormBlends is not affiliated with, endorsed by, or sponsored by Novo Nordisk.